HARBOR CAPITAL ADVISORS, INC.

Position in SRPT — Sarepta Therapeutics, Inc.

CIK 1039128 CHICAGO, IL

Position in SRPT

as of Mar 31, 2026 · filed Apr 28, 2026 Compact

Position Value

$1,742,649

+$1,719,992 QoQ

Shares Held

80,085

+5944.2% QoQ

Ownership

0.076%

of shares outstanding

% of Portfolio

0.16%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Dec 2022

12 quarters on record

Voting authority Sole 100.ToString("F0")% Shared 0.ToString("F0")% None 0.ToString("F0")%

Healthcare · as of Mar 31, 2026

HARBOR CAPITAL ADVISORS, INC. holds $23,126,231 across 27 Biotechnology names. SRPT ranks #7 (7.5% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	KYMR	Kymera Therapeutics, Inc.	33,948	$2,827,528
2	RYTM	Rhythm Pharmaceuticals, Inc.	30,353	$2,639,800
3	TARS	Tarsus Pharmaceuticals, Inc.	29,283	$2,054,202
4	VCEL	Vericel Corp	63,718	$2,049,808
5	HALO	Halozyme Therapeutics, Inc.	31,355	$2,026,473
6	RARE	Ultragenyx Pharmaceutical Inc.	83,196	$1,742,956
7	SRPT	Sarepta Therapeutics, Inc. This page	80,085	$1,742,649
8	AGIO	Agios Pharmaceuticals, Inc.	43,005	$1,454,859

12 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$1,742,649	80,085	+5944.2%	Shares	Sole	2026-04-28
2025-06-30	$22,657	1,325	+190.6%	Shares	Sole	2025-07-09
2025-03-31	$29,101	456	-73.3%	Shares	Sole	2025-04-14
2024-12-31	$207,432	1,706	+33.4%	Shares	Sole	2025-01-10
2024-09-30	$159,734	1,279	+0.5%	Shares	Sole	2024-10-29
2024-06-30	$201,134	1,273	-5.7%	Shares	Sole	2024-07-09
2024-03-31	$174,771	1,350	-24.6%	Shares	Sole	2024-05-13
2023-12-31	$172,609	1,790	-44.8%	Shares	Sole	2024-01-08
2023-09-30	$393,237	3,244	+6.4%	Shares	Sole	2023-10-20
2023-06-30	$349,056	3,048	-25.9%	Shares	Sole	2023-07-11
2023-03-31	$566,894	4,113	+80.1%	Shares	Sole	2023-04-26
2022-12-31	$295,960	2,284	—	Shares	Sole	2023-01-20
No filing history on record for this holder in this stock.